Form 4: Tempus AI Director David Epstein Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Director David Epstein sold 370 shares of Tempus AI, Inc. Class A Common Stock at $53.31 per share on February 3, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- On February 3, 2025, David R. Epstein, a director of Tempus AI, Inc., sold 370 shares of Class A Common Stock.
- The sale was executed at a price of $53.31 per share.
- The transaction was conducted under a Rule 10b5-1 trading plan adopted on August 27, 2024.
- Following the transaction, Epstein directly owns 27,524 shares of Tempus AI, Inc. Class A Common Stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports a routine stock sale under a pre-arranged trading plan. There is no indication of positive or negative implications for the company.
Industry Context
Sales by company insiders are a common occurrence and are often pre-planned through Rule 10b5-1 trading plans to avoid accusations of trading on inside information. The market typically views these sales in the context of the overall trading activity and company performance.
Stakeholder Impact
- The sale of shares by a director could have a minor impact on shareholder sentiment, but is unlikely to be significant given the relatively small number of shares sold and the existence of a pre-arranged trading plan.
Key Dates
| Date | Description |
|---|---|
| 2024-08-27 | Date the Reporting Person adopted the Rule 10b5-1 trading plan |
| 2025-02-03 | Date of the transaction (sale of shares) |
| 2025-02-05 | Date of signature for the Form 4 filing |
Keywords
Form 4, Tempus AI, David Epstein, stock sale, 10b5-1 trading plan, director, Class A Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.